首页|人脐带间充质干细胞制剂大规模生产中稳定性研究

人脐带间充质干细胞制剂大规模生产中稳定性研究

扫码查看
人脐带间充质干细胞在再生医学中应用广泛,但较少有研究关注间充质干细胞制剂生产中的稳定性.本研究通过对生产过程中细胞原液、半成品稳定性研究及制剂复苏稳定性研究,为生产过程提供依据,为制剂复苏使用方法提供参考.采用3批次细胞制剂,取生产过程中细胞原液、半成品分别静置在低温(2~8 ℃)及室温(20~26 ℃)条件下储存,细胞原液储存时间间隔为0、2、4、6h,半成品储存时间间隔为0、1、2、3h,考察项目包括外观检查、活细胞浓度、细胞活率、细胞表面标记、淋巴细胞增殖抑制率及无菌检查.此外,取细胞制剂复苏后分别进行稀释和培养稳定性探索,复苏稀释液分别为0.9%氯化钠注射液、0.9%氯化钠注射液+1%人血白蛋白、0.9%氯化钠注射液+2%人血白蛋白,稀释倍数包括10倍及40倍,稀释后静置时间间隔为0、1、2、3、4h.复苏培养液分别为DMEM培养基、DMEM+2%血小板裂解物、0.9%氯化钠注射液、0.9%氯化钠注射液+1%人血白蛋白,培养时间为24 h.考察项目为活细胞浓度及细胞活率.实验结果表明,细胞原液在低温(2~8 ℃)及室温(20~26 ℃)条件下静置6 h内均维持稳定,细胞半成品在同样条件下静置3 h内维持稳定.制剂复苏后,使用含1%或2%人血白蛋白的氯化钠注射液稀释,在4 h内细胞活率维持在80%以上.不同稀释倍数对细胞活性存在影响.制剂复苏后,使用含2%血小板裂解物的完全培养基培养24 h后,细胞活率达到80%以上.综上表明,细胞原液在6 h内、细胞半成品在3 h内稳定性均满足要求,细胞制剂复苏后稀释液中添加1%或2%人血白蛋白更好保护细胞活性.
Stability study of umbilical cord mesenchymal stem cells formulation in large-scale production
Umbilical cord mesenchymal stem cells(UC-MSCs)have been widely used in regenerative medicine,but there is limited research on the stability of UC-MSCs formulation during production.This study aims to assess the stability of the cell stock solution and intermediate product throughout the production process,as well as the final product following reconstitution,in order to offer guidance for the manufacturing process and serve as a reference for formulation reconstitution methods.Three batches of cell formulation were produced and stored under low temperature(2-8 ℃)and room temperature(20-26 ℃)during cell stock solution and intermediate product stages.The storage time intervals for cell stock solution were 0,2,4,and 6 h,while for intermediate products,the intervals were 0,1,2,and 3 h.The evaluation items included visual inspection,viable cell concentration,cell viability,cell surface markers,lymphocyte proliferation inhibition rate,and sterility.Additionally,dilution and culture stability studies were performed after reconstitution of the cell product.The reconstitution diluents included 0.9%sodium chloride injection,0.9%sodium chloride injection+1%human serum albumin,and 0.9%sodium chloride injection+2%human serum albumin,with dilution ratios of 10-fold and 40-fold.The storage time intervals after dilution were 0,1,2,3,and 4 h.The reconstitution culture media included DMEM medium,DMEM+2%platelet lysate,0.9%sodium chloride injection,and 0.9%sodium chloride injection+1%human serum albumin,and the culture duration was 24 h.The evaluation items were viable cell concentration and cell viability.The results showed that the cell stock solution remained stable for up to 6 h under both low temperature(2-8 ℃)and room temperature(20-26 ℃)conditions,while the intermediate product remained stable for up to 3 h under the same conditions.After formulation reconstitution,using sodium chloride injection diluted with 1%or 2%human serum albumin maintained a viability of over 80%within 4 h.It was observed that different dilution factors had an impact on cell viability.After formulation reconstitution,cultivation in medium with 2%platelet lysate resulted in a cell viability of over 80%after 24 h.In conclusion,the stability of cell stock solution within 6 h and intermediate product within 3 h meets the requirements.The addition of 1%or 2%human serum albumin in the reconstitution diluent can better protect the post-reconstitution cell viability.

umbilical cord mesenchymal stem cellproductioncell stock solutioncell intermediate productcell productstability

储王龙、李童婧、上官燕、何方涛、吴建福、曾秀萍、郭涛、王清芳、张芬、钟振忠、梁晓、胡隽源、刘沐芸

展开 >

深圳市北科生物科技有限公司,广东深圳 518057

哈尔滨北科健康科技有限公司,黑龙江哈尔滨 150000

深圳科诺医学检验实验室,广东深圳 518000

细胞产业关键共性技术国家工程研究中心,广东深圳 518000

展开 >

间充质干细胞 生产 原液 半成品 制剂 稳定性

细胞产业关键共性技术国家工程研究中心创新能力建设项目哈尔滨市细胞制剂数字化智能化生产线开发和推广应用项目

发改高技2023447号哈松发改函202379号

2024

药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
年,卷(期):2024.59(3)
  • 22